packageRanibizumab

ranibizumab

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Ranibizumab is an eye injection used to treat retinal diseases such as wet age-related macular degeneration, macular edema, diabetic retinopathy, and retinal vein occlusion. It is widely used and authorised in the European Union, where several products are approved.

Summary written by glm-5.3-flash from Wikidata Q414270 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:ranibizumab
ATC codes:S01LA04
DrugBank:DB01270
Wikidata:Q414270
molar mass:48349.6 g/mol (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown